العلاج الكيميائي السام للخلايا لورم الغدد الصماء المتعدد من النوع 2A لدى مرضى مختارين

References

DOI: 10.1089/thy.2014.0335

• Single agent or combination cytotoxic chemotherapeutic regimens administered to patients with MTC are characterized by low response rates (15%–20%) of short duration, although they may be indicated in selected patients.
• The most effective regimens are combination therapy with doxorubicin and another agent, or 5-fluorouracil and dacarbazine.